Thank you for visiting PDI Healthcare's US Website.

We notice that you are visiting us from . This site only services US-based visitors. Would you like to visit the site that is appropriate for your location?

*By selecting “yes” we will redirect you to and remember your choice for future visits.

« Back to results

Prevantics® Device Swab In-Service Video (IFU)

Type: Video

For new hire training or yearly refresher, this in-service video covers a basic product overview and instructions for use of the Prevantics Device Swab.

Effectively Scrub the Hub prior to and between each line access with Prevantics Device Swab

  • First and only 3.15% (w/v) Chlorhexidine gluconate (CHG) and 70% (v/v) Isopropyl alcohol (IPA) solution to receive 510k clearance from the US Food and Drug Administration (FDA) for disinfecting needleless access sites prior to use.
  • Intuitive, easy-to-use prep pad format can be used prior to initial access, and between each access.
  • Friction removes microorganisms from grooves and threads of connectors.
  • Strip format hangs conveniently on an IV pole for point-of-care accessibility.


> View Prevantics Device Swab Product Page

Frequently Asked Questions

  • How is Prevantics® Device Swab used?

    Show Answer
    Prevantics Device Swab is designed to disinfect needleless access sites (or to scrub the hub) prior to use as well as in between each line access. Prevantics Device Swab is used to scrub the access site for 5 seconds with drying of the access site for at least 5 seconds.
  • If I use the Prevantics® Device Swab product, will I still need to use an alcohol impregnated cap?

    Show Answer
    Not necessarily. If clinicians follow all existing infection prevention and control measures, such as hand hygiene, use of personal protective equipment, use of chlorhexidine-based skin antisepsis, etc. then the use of an alcohol impregnated cap may not be clinically indicated. This would be evaluated by ongoing surveillance of HAI rates.
  • What evidence-based clinical guidelines support the use of the Prevantics® Device Swab for disinfection of needleless access sites prior to use?

    Show Answer
    The following evidence-based clinical guidelines support the use of Chlorhexidine Gluconate/Alcohol for disinfection of needleless access sites prior to use: 1. Guidelines for the Prevention of Intravascular Catheter-Related Infections, US Centers for Disease Control and Prevention (CDC) 2. Standards of Practice, Infusion Nurses Society (INS) 3. Strategies to Prevent Central-Line Associated Bloodstream Infections in Acute Care Hospitals, Society for Healthcare Epidemiology of America (SHEA) 4. National Patient Safety Goals, The Joint Commission 5. Clinical Practice Guidelines for Diagnosis and Management of Intravascular Catheter-Related Infection, Infectious Disease Society of America (IDSA) 6. Elimination Guide to Infections in Hemodialysis Settings, Association for Professionals in Infection Control and Epidemiology (APIC) 
  • Where is Prevantics® Device Swab used?

    Show Answer
    Prevantics Device Swab is used on needleless access sites which include ports, hubs, connectors, dialysis connectors and blood collection applications. These needleless access sites are most commonly found on patients who require an IV (central line, mid-line, or peripheral line).
  • Why is the Prevantics® Device Swab solution beneficial?

    Show Answer
    By using an antiseptic to disinfect the needleless access site, you are decreasing the risk of the patient acquiring a bloodstream infection (BSI) which can be fatal to the patient. According to the CDC, “Disinfection of the devices with Chlorhexidine /alcohol solution appears to be most effective in reducing colonization”.


Not recently active